Jazz Pharmaceuticals plc (JAZZ)
USD 120.05
(2.45%)
USD 120.05
(2.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.1 Billion USD | -11.4% |
| 2022 | 5.76 Billion USD | -5.58% |
| 2021 | 6.1 Billion USD | 207.06% |
| 2020 | 1.98 Billion USD | 15.27% |
| 2019 | 1.72 Billion USD | 10.37% |
| 2018 | 1.56 Billion USD | 1.47% |
| 2017 | 1.54 Billion USD | -22.73% |
| 2016 | 1.99 Billion USD | 70.84% |
| 2015 | 1.16 Billion USD | -12.46% |
| 2014 | 1.33 Billion USD | 144.85% |
| 2013 | 544.4 Million USD | 27.47% |
| 2012 | 427.07 Million USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 24.62 Million USD | -72.97% |
| 2009 | 91.1 Million USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 75.11 Million USD | 1.12% |
| 2006 | 74.28 Million USD | 0.89% |
| 2005 | 73.62 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 5.1 Billion USD | -0.08% |
| 2024 Q1 | 5.1 Billion USD | -0.06% |
| 2023 Q4 | 5.1 Billion USD | -1.25% |
| 2023 Q2 | 5.75 Billion USD | -0.17% |
| 2023 Q1 | 5.76 Billion USD | -0.06% |
| 2023 Q3 | 5.17 Billion USD | -10.08% |
| 2023 FY | 5.1 Billion USD | -11.4% |
| 2022 Q4 | 5.76 Billion USD | -0.06% |
| 2022 Q2 | 6.06 Billion USD | -0.13% |
| 2022 FY | 5.76 Billion USD | -5.58% |
| 2022 Q1 | 6.07 Billion USD | -0.49% |
| 2022 Q3 | 5.76 Billion USD | -4.93% |
| 2021 Q3 | 6.33 Billion USD | -4.65% |
| 2021 Q2 | 6.64 Billion USD | 234.12% |
| 2021 FY | 6.1 Billion USD | 207.06% |
| 2021 Q1 | 1.98 Billion USD | 0.03% |
| 2021 Q4 | 6.1 Billion USD | -3.64% |
| 2020 Q2 | 2.21 Billion USD | 28.41% |
| 2020 Q1 | 1.72 Billion USD | -0.06% |
| 2020 Q4 | 1.98 Billion USD | 0.15% |
| 2020 Q3 | 1.98 Billion USD | -10.31% |
| 2020 FY | 1.98 Billion USD | 15.27% |
| 2019 Q3 | 1.72 Billion USD | 0.0% |
| 2019 Q4 | 1.72 Billion USD | 0.05% |
| 2019 FY | 1.72 Billion USD | 10.37% |
| 2019 Q1 | 1.71 Billion USD | 10.0% |
| 2019 Q2 | 1.72 Billion USD | 0.28% |
| 2018 Q4 | 1.56 Billion USD | 0.16% |
| 2018 Q2 | 1.55 Billion USD | 1.38% |
| 2018 Q1 | 1.53 Billion USD | -0.22% |
| 2018 FY | 1.56 Billion USD | 1.47% |
| 2018 Q3 | 1.56 Billion USD | 0.15% |
| 2017 Q3 | 1.54 Billion USD | -5.62% |
| 2017 Q2 | 1.63 Billion USD | -5.97% |
| 2017 FY | 1.54 Billion USD | -22.73% |
| 2017 Q1 | 1.73 Billion USD | -12.74% |
| 2017 Q4 | 1.54 Billion USD | -0.22% |
| 2016 Q1 | 1.14 Billion USD | -1.76% |
| 2016 FY | 1.99 Billion USD | 70.84% |
| 2016 Q4 | 1.99 Billion USD | -7.16% |
| 2016 Q3 | 2.14 Billion USD | 88.09% |
| 2016 Q2 | 1.14 Billion USD | -0.42% |
| 2015 Q1 | 1.33 Billion USD | 0.12% |
| 2015 FY | 1.16 Billion USD | -12.46% |
| 2015 Q2 | 1.33 Billion USD | 0.25% |
| 2015 Q3 | 1.17 Billion USD | -12.4% |
| 2015 Q4 | 1.16 Billion USD | -0.44% |
| 2014 FY | 1.33 Billion USD | 144.85% |
| 2014 Q4 | 1.33 Billion USD | 0.12% |
| 2014 Q3 | 1.33 Billion USD | 12.16% |
| 2014 Q2 | 1.18 Billion USD | -0.18% |
| 2014 Q1 | 1.18 Billion USD | 118.42% |
| 2013 Q3 | 545.56 Million USD | -0.21% |
| 2013 FY | 544.4 Million USD | 27.47% |
| 2013 Q4 | 544.4 Million USD | -0.21% |
| 2013 Q2 | 546.72 Million USD | 30.64% |
| 2013 Q1 | 418.5 Million USD | -2.01% |
| 2012 FY | 427.07 Million USD | 0.0% |
| 2012 Q4 | 427.07 Million USD | -1.96% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | 444.19 Million USD | 0.0% |
| 2012 Q3 | 435.63 Million USD | -1.93% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q1 | 20.56 Million USD | -16.48% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q3 | 28.7 Million USD | -12.22% |
| 2010 FY | 24.62 Million USD | -72.97% |
| 2010 Q2 | 32.69 Million USD | -59.04% |
| 2010 Q1 | 79.81 Million USD | -12.39% |
| 2010 Q4 | 24.62 Million USD | -14.18% |
| 2009 FY | 91.1 Million USD | 0.0% |
| 2009 Q4 | 91.1 Million USD | -21.03% |
| 2009 Q3 | 115.36 Million USD | 0.45% |
| 2009 Q2 | 114.84 Million USD | 977.55% |
| 2009 Q1 | 10.65 Million USD | 0.0% |
| 2008 Q3 | 113.61 Million USD | -0.08% |
| 2008 Q4 | - USD | -100.0% |
| 2008 Q2 | 113.7 Million USD | 0.3% |
| 2008 FY | - USD | -100.0% |
| 2008 Q1 | 113.36 Million USD | 50.92% |
| 2007 Q4 | 75.11 Million USD | 0.34% |
| 2007 Q1 | 74.42 Million USD | 0.2% |
| 2007 Q2 | 74.62 Million USD | 0.26% |
| 2007 Q3 | 74.86 Million USD | 0.32% |
| 2007 FY | 75.11 Million USD | 1.12% |
| 2006 FY | 74.28 Million USD | 0.89% |
| 2006 Q4 | 74.28 Million USD | 0.0% |
| 2005 Q4 | 73.62 Million USD | 0.0% |
| 2005 FY | 73.62 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -15140.901% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -453943.378% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -23218027.273% |
| Autolus Therapeutics plc | 47.91 Million USD | -10560.742% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -744504.665% |
| Shattuck Labs, Inc. | 3.4 Million USD | -149870.288% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -22779.101% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -157620.592% |
| Aptose Biosciences Inc. | 621 Thousand USD | -822442.351% |
| Precision BioSciences, Inc. | 7.72 Million USD | -66039.946% |
| Dyadic International, Inc. | 88.87 Thousand USD | -5747607.888% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -19031.041% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -3701340.58% |
| Nektar Therapeutics | 112.62 Million USD | -4435.394% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -54327.15% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -5159483.838% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -104017.163% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -3809.374% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -62922.677% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -6997143.836% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 34.67 Million USD | -14632.314% |
| INmune Bio, Inc. | 397 Thousand USD | -1286546.851% |
| Opthea Limited | 200.53 Million USD | -2447.171% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -10162.774% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -34216.345% |
| Verastem, Inc. | 40.08 Million USD | -12642.573% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -115937.892% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -50705.53% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -77753.803% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -88657.394% |
| NextCure, Inc. | 5.94 Million USD | -85762.969% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -5667633.345% |
| Organovo Holdings, Inc. | 888 Thousand USD | -575123.874% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 800 Thousand USD | -638398.5% |
| Ovid Therapeutics Inc. | 30 Million USD | -16926.627% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -26933.543% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -20762.555% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -6647.672% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -19616.633% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -14681.769% |
| Senti Biosciences, Inc. | 33.53 Million USD | -15130.449% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -1913004.12% |
| PureTech Health plc | 18.25 Million USD | -27888.975% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -3522650.345% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -45543.714% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -6421.196% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 2.57 Million USD | -198268.466% |
| Beam Therapeutics Inc. | 159.91 Million USD | -3094.269% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -7074.544% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -21988.597% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -5390.512% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 40.14 Million USD | -12624.163% |
| Mesoblast Limited | 100.48 Million USD | -4983.435% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -2575.292% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -5146.495% |
| MediWound Ltd. | 6.35 Million USD | -80340.756% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -4977.624% |
| Fortress Biotech, Inc. | 60.85 Million USD | -8293.565% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -1391.462% |
| Achilles Therapeutics plc | 1.07 Million USD | -474620.074% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -4930.32% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -63376.923% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -8878.079% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -72808.764% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -17029.978% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -692.102% |
| FibroGen, Inc. | 89.69 Million USD | -5594.714% |
| Celcuity Inc. | 37.03 Million USD | -13692.173% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -117676.989% |
| ContextLogic Inc. | 6 Million USD | -85033.133% |
| GH Research PLC | 631 Thousand USD | -809406.815% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -134285.372% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -13805272.973% |
| ImmuCell Corporation | 10.54 Million USD | -48360.604% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -257879.192% |
| Amarin Corporation plc | 8.73 Million USD | -58363.866% |
| TG Therapeutics, Inc. | 100.11 Million USD | -5001.968% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -94544.951% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -281486.99% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -13873.432% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -987905.416% |
| Aptorum Group Limited | 3.05 Million USD | -166909.58% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -16606.967% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -529.632% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -1616351.899% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -4782.98% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -13339817.996% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -114480.26% |
| Ardelyx, Inc. | 51.54 Million USD | -9809.38% |
| Ainos, Inc. | 5.92 Million USD | -86160.908% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -23716.795% |
| Prothena Corporation plc | 10.72 Million USD | -47544.697% |
| HilleVax, Inc. | 25.24 Million USD | -20134.464% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -25631.641% |
| Celularity Inc. | 26.17 Million USD | -19413.267% |
| Rallybio Corporation | 173 Thousand USD | -2952494.22% |
| Cue Biopharma, Inc. | 4.2 Million USD | -121460.876% |
| Omeros Corporation | 329.7 Million USD | -1449.26% |
| Humacyte, Inc. | 38.6 Million USD | -13133.13% |
| Immunocore Holdings plc | 82.64 Million USD | -6080.712% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -316576.255% |
| Blueprint Medicines Corporation | 610.96 Million USD | -736.057% |
| IO Biotech, Inc. | 1.83 Million USD | -277658.999% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -350242.112% |
| Summit Therapeutics Inc. | 103.29 Million USD | -4845.288% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -5266.154% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -10392.129% |
| Pulmatrix, Inc. | 8.32 Million USD | -61242.476% |
| Elicio Therapeutics, Inc. | 6 Million USD | -84933.927% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -9260.432% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -39359.158% |
| Acelyrin, Inc. | 1.19 Million USD | -427704.69% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -5179.738% |
| Cytokinetics, Incorporated | 607.37 Million USD | -740.997% |
| Vor Biopharma Inc. | 31.83 Million USD | -15947.716% |
| Evogene Ltd. | 10.65 Million USD | -47848.822% |
| Replimune Group, Inc. | 71.99 Million USD | -6995.413% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -672889.196% |
| PDS Biotechnology Corporation | 19.5 Million USD | -26086.507% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -19402726.103% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | -194.288% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 6.62 Million USD | -76966.807% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -7020.04% |
| Atai Life Sciences N.V. | 15.21 Million USD | -33480.882% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -2003032.549% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -325249.554% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -11737.747% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -1243748.439% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -373018.188% |
| MiMedx Group, Inc. | 48.09 Million USD | -10519.738% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -770220.571% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -2768.528% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -1697.239% |
| Mereo BioPharma Group plc | 5.3 Million USD | -96277.132% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -868605.442% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -22407.107% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 38.21 Million USD | -13266.448% |
| scPharmaceuticals Inc. | 38.81 Million USD | -13061.186% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -59095.596% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Precigen, Inc. | 5.89 Million USD | -86549.5% |
| XOMA Corporation | 118.51 Million USD | -4209.884% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -50629.844% |
| Incyte Corporation | 29.16 Million USD | -17415.904% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -13675.959% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -64566.262% |
| Seer, Inc. | 25.96 Million USD | -19573.348% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | -2190.506% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -20361.416% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -34053153.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -1836050.832% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | -2940.18% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -3751001.907% |
| UroGen Pharma Ltd. | 98.55 Million USD | -5083.091% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -3325.559% |
| Entera Bio Ltd. | 256 Thousand USD | -1995207.813% |
| Lisata Therapeutics, Inc. | 137.00 USD | -3728458294.161% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -106918.395% |
| Chimerix, Inc. | 125 Thousand USD | -4086290.4% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -795536.76% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -3593.305% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 16.03 Million USD | -31751.269% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -72971157.143% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -357351.924% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -40980.811% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -7634587.99% |
| AbCellera Biologics Inc. | 71.22 Million USD | -7071.924% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -275560.443% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -130416.374% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -12644.481% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -6239.42% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -9744.067% |
| bluebird bio, Inc. | 224.41 Million USD | -2176.094% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -761.243% |
| DBV Technologies S.A. | 4.52 Million USD | -112758.772% |
| Fortress Biotech, Inc. | 60.85 Million USD | -8293.565% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -82114.518% |
| CorMedix Inc. | 517.01 Thousand USD | -987880.573% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -1253.959% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -135426.347% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -491999.037% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -297394.933% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -550329.741% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -58017.966% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -29143.648% |
| Onconetix, Inc. | 118.85 Thousand USD | -4297491.223% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -117136.355% |
| Adagene Inc. | 13.54 Million USD | -37625.075% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -2368.009% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -7641555.197% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -884.754% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -7793.051% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -29783.508% |
| SciSparc Ltd. | 24 Thousand USD | -21283183.333% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -6127.976% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -133442.17% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -35237.518% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -2431.226% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | -118.008% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -22208543.478% |
| 2seventy bio, Inc. | 244.01 Million USD | -1993.326% |
| ADMA Biologics, Inc. | 130.59 Million USD | -3811.35% |
| Clene Inc. | 7.15 Million USD | -71320.414% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -151191.355% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -1962.858% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -463840.781% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -1943098.22% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -2551.847% |
| Absci Corporation | 4.66 Million USD | -109513.476% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | -88.982% |
| Surrozen, Inc. | 882 Thousand USD | -579036.961% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -19615.872% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -22084.53% |
| Cingulate Inc. | 135.09 Thousand USD | -3780822.139% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -16381.102% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -10586.167% |
| Kronos Bio, Inc. | 25.37 Million USD | -20026.829% |
| Innoviva, Inc. | 446.23 Million USD | -1044.688% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -29193.961% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -8368.009% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -505174.133% |
| AlloVir, Inc. | 16.64 Million USD | -30582.292% |
| Century Therapeutics, Inc. | 46.65 Million USD | -10847.722% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -68462411.728% |
| Kura Oncology, Inc. | 9.33 Million USD | -54636.262% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -75316.92% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -1110332.174% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -2839.798% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -125890.637% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -3475927.738% |
| HCW Biologics Inc. | 6.3 Million USD | -80923.641% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -7667.976% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -11078.929% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -979.071% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -8306111.786% |
| Histogen Inc. | 4.38 Million USD | -116414.325% |
| Surrozen, Inc. | 882 Thousand USD | -579036.961% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | -5007.988% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -204220.337% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -5486224.97% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -7803.799% |
| Avalo Therapeutics, Inc. | 2 Million USD | -255299.4% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | -264.758% |
| Turnstone Biologics Corp. | 1.18 Million USD | -429503.701% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -4686127.523% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -6128.57% |
| Exelixis, Inc. | 189.94 Million USD | -2589.207% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -11813.119% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -20007.023% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | -1675.271% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -281486.99% |
| Arcellx, Inc. | 50.84 Million USD | -9946.986% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -3225.665% |
| Insmed Incorporated | 1.19 Billion USD | -328.037% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -350242.112% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -23951.172% |
| Moolec Science SA | 99.04 Thousand USD | -5157087.569% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -18393.132% |
| Geron Corporation | 35.05 Million USD | -14473.016% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -864195.77% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -11813.953% |
| Royalty Pharma plc | 6.13 Billion USD | 16.744% |
| OmniAb, Inc. | 22.07 Million USD | -23039.243% |
| Alector, Inc. | 30.45 Million USD | -16671.697% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -310983.313% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -21966.649% |
| Humacyte, Inc. | 38.6 Million USD | -13133.13% |
| Structure Therapeutics Inc. | 4.01 Million USD | -127186.02% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -1097.386% |
| 89bio, Inc. | 24.79 Million USD | -20500.879% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -30178.53% |
| Immunic, Inc. | 639 Thousand USD | -799272.144% |
| Veracyte, Inc. | 7.52 Million USD | -67780.239% |
| Genelux Corporation | 1.86 Million USD | -273639.979% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -494860.078% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -3903209.568% |
| Immunovant, Inc. | - USD | -Infinity% |
| Vericel Corporation | 81.85 Million USD | -6140.212% |
| Fortrea Holdings Inc. | 1.63 Billion USD | -212.913% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -84820.831% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -3619.662% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -8538544.646% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -11191.865% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -11301.25% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -3755773.529% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -1137402.255% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -81445.147% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -423447.927% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -1042346.531% |
| United Therapeutics Corporation | 300 Million USD | -1602.663% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -2975.156% |
| XOMA Corporation | 118.51 Million USD | -4209.884% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | -4242.493% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -90951.48% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -25314.14% |
| uniQure N.V. | 130.06 Million USD | -3827.258% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -62636.281% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -3399536.608% |
| Windtree Therapeutics, Inc. | 15 Million USD | -33953.253% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -8618.191% |
| Pluri Inc. | 29.05 Million USD | -17481.62% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 72.11 Million USD | -6982.722% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -142700.895% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -5519.287% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -1216.974% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -90951.48% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -1089023.241% |
| Nutriband Inc. | 79.82 Thousand USD | -6398802.613% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -113815.879% |
| Compugen Ltd. | 719 Thousand USD | -710329.485% |
| Roivant Sciences Ltd. | 477.85 Million USD | -968.939% |
| ProKidney Corp. | 3.61 Million USD | -141395.512% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -7799664.846% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -13766.084% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -606269.266% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -100728.82% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 7.83 Million USD | -65136.117% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -237480.837% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -44232.477% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -50954.353% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -5941.024% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -44297.983% |
| Imunon, Inc. | 1.13 Million USD | -448247.177% |
| BioAtla, Inc. | 836 Thousand USD | -610903.349% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -5681.799% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -108372.882% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -37003.131% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -4323.266% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -25180.812% |
| Galecto, Inc. | 66 Thousand USD | -7739275.758% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -35237.518% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -240.703% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -5033.244% |
| PolyPid Ltd. | 6.37 Million USD | -79975.059% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -5487.997% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 14.64 Million USD | -34785.863% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -3405225.333% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -3751001.907% |
| Instil Bio, Inc. | 81.42 Million USD | -6173.089% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -770220.571% |
| OncoCyte Corporation | 2.2 Million USD | -231659.891% |
| Elevation Oncology, Inc. | 30.13 Million USD | -16849.225% |
| Purple Biotech Ltd. | 163 Thousand USD | -3133634.969% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -201398.54% |
| MacroGenics, Inc. | 30.19 Million USD | -16816.108% |
| Verona Pharma plc | 48.37 Million USD | -10459.367% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -547379.957% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -55325.217% |
| Aditxt, Inc. | 1.04 Million USD | -490230.446% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -19286.625% |
| Curis, Inc. | 1.48 Million USD | -342948.22% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -732002.363% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -85133033.333% |
| BeiGene, Ltd. | 197.61 Million USD | -2484.779% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -381093.134% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -6009297.647% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -135498.301% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -9600.308% |
| Adicet Bio, Inc. | 17.7 Million USD | -28753.799% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -37084.16% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | -5589.83% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -22924.512% |
| Invivyd, Inc. | 722 Thousand USD | -707377.562% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -10431.5% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -174707824.466% |
| Moolec Science SA | 99.04 Thousand USD | -5157087.569% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -12065.352% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -52892.925% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -4474.058% |
| Evaxion Biotech A/S | 8.48 Million USD | -60073.625% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -6717.468% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -82074.839% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -21600.106% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -2837671.111% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -613103.842% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -160125.471% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -545625.214% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -37908.691% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -10641.222% |
| ImmunityBio, Inc. | 836.95 Million USD | -510.308% |
| Korro Bio, Inc. | 31.21 Million USD | -16263.365% |
| Kineta, Inc. | 150 Thousand USD | -3405225.333% |
| BioVie Inc. | 349.89 Thousand USD | -1459767.274% |
| Codexis, Inc. | 12.24 Million USD | -41621.702% |
| Celularity Inc. | 26.17 Million USD | -19413.267% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -2896487.938% |
| Cibus, Inc. | 17.67 Million USD | -28801.143% |
| Annexon, Inc. | 29.19 Million USD | -17399.102% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -455157.398% |
| Eyenovia, Inc. | 8.95 Million USD | -56926.418% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -7679.57% |
| NeurAxis, Inc. | 27.07 Thousand USD | -18868755.971% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -484069.479% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -952882.836% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -16092105.91% |
| Notable Labs, Ltd. | 1.52 Million USD | -334630.537% |
| IN8bio, Inc. | 3.37 Million USD | -151068.63% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -1611252.681% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -10141.169% |
| Lumos Pharma, Inc. | 6 Million USD | -85033.133% |
| Liquidia Corporation | 2.36 Million USD | -215973.942% |
| Mustang Bio, Inc. | 1.97 Million USD | -258140.04% |
| Quantum-Si incorporated | 13.73 Million USD | -37084.16% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -73364.519% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -55325.217% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -13805272.973% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -25621830.177% |
| Vaxcyte, Inc. | 22.11 Million USD | -23001.569% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -53086.047% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -51339.96% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -30409.235% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -3929121.538% |
| PepGen Inc. | 17.1 Million USD | -29771.275% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -1077534.599% |
| Solid Biosciences Inc. | 23.94 Million USD | -21235.734% |
| Palisade Bio, Inc. | 90 Thousand USD | -5675442.222% |
| Nutriband Inc. | 79.82 Thousand USD | -6398802.613% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -122604.05% |
| Belite Bio, Inc | 578 Thousand USD | -883634.948% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -39292115.385% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -2632883.505% |
| Altimmune, Inc. | 175 Thousand USD | -2918750.286% |
| Peak Bio, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -117676.989% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -368707.798% |
| Neurogene Inc. | 13.37 Million USD | -38096.276% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -1566.984% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -19349.37% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -33168.126% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -51339.96% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -3040369.048% |
| Immunome, Inc. | 1.34 Million USD | -381093.134% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -218751.243% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -510698.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -12509.825% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -46201.282% |
| Athira Pharma, Inc. | 1.21 Million USD | -419619.638% |
| XOMA Corporation | 118.51 Million USD | -4209.884% |
| Merus N.V. | 10.48 Million USD | -48603.166% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -37936.995% |
| Rezolute, Inc. | 1.66 Million USD | -307610.12% |
| Clene Inc. | 7.15 Million USD | -71320.414% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -6963945.373% |
| BeyondSpring Inc. | 3.36 Million USD | -151742.687% |
| Synlogic, Inc. | 12.49 Million USD | -40793.347% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -15541.805% |
| Krystal Biotech, Inc. | 6.62 Million USD | -77059.94% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -2888.543% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -85089.927% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -10782843.151% |
| MannKind Corporation | 252.15 Million USD | -1925.766% |
| Ikena Oncology, Inc. | 7.18 Million USD | -71041.894% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -2566728.141% |
| Gossamer Bio, Inc. | 197.4 Million USD | -2487.568% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -982205.385% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -1715.67% |
| Mural Oncology plc | 8.91 Million USD | -57222.276% |
| Disc Medicine, Inc. | 1.43 Million USD | -355609.471% |
| Champions Oncology, Inc. | 6.09 Million USD | -83733.711% |
| REGENXBIO Inc. | 82.22 Million USD | -6112.435% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -1033899.389% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -115100.451% |
| Vaxart, Inc. | 2.62 Million USD | -194638.391% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -1880387.868% |
| Cellectis S.A. | 36.24 Million USD | -13994.501% |
| Longeveron Inc. | 1.44 Million USD | -352661.602% |
| Repare Therapeutics Inc. | 1.01 Million USD | -505641.386% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -351.03% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -11309.654% |
| Revolution Medicines, Inc. | 80.57 Million USD | -6239.42% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -159126.559% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -2885768.927% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -4152735.772% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -604.842% |
| Denali Therapeutics Inc. | 44.98 Million USD | -11255.879% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -40750.015% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -3780822.139% |
| Passage Bio, Inc. | 22.92 Million USD | -22185.188% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -84483.342% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -789388.099% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -25230.96% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -1253526.272% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -429865.32% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -1096034.764% |
| OmniAb, Inc. | 22.07 Million USD | -23039.243% |
| Anew Medical, Inc. | 1.54 Million USD | -331587.532% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -17180.077% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -56448.079% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -16329.682% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -125890.637% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -9807.458% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -80125.978% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -36052.509% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -760017.262% |
| Alumis Inc. Common Stock | 30.86 Million USD | -16452.132% |
| Equillium, Inc. | 384 Thousand USD | -1330105.208% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -82835.347% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -168591.81% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -25833046.209% |
| vTv Therapeutics Inc. | 169 Thousand USD | -3022378.107% |
| Bio-Techne Corporation | 319 Million USD | -1501.25% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -8863.269% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -2760.56% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -33053.683% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -41150.004% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -106161.452% |
| Nkarta, Inc. | 82.27 Million USD | -6108.81% |
| BioCardia, Inc. | 982 Thousand USD | -520061.711% |
| Iterum Therapeutics plc | 18.95 Million USD | -26846.55% |